• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Oncolytics Biotech Inc

+ Add to Watchlist

ONY:GR

0.369 EUR 0.055 12.97%

As of 15:19:14 ET on 12/23/2014.

Snapshot for Oncolytics Biotech Inc (ONY)

Open: 0.404 Day's Range: 0.364 - 0.437 Volume: 0
Previous Close: 0.424 52wk Range: 0.280 - 1.500 1-Yr Rtn: -68.38%

Stock Chart for ONY

No chart data available.
  • ONY:GR 0.377
  • 1D
  • 1M
  • 1Y
0.424
Interactive ONY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ONY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2014) -0.2580
Est. PEG Ratio -
Market Cap (M EUR) 33.05
Shares Outstanding (M) 89.57
30 Day Average Volume 1,364
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ONY

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for ONY

Oncolytics Biotech Inc. discovers and develops pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics. The Company is focusing on the development of the reovirus known as REOLYSIN as a potential cancer therapeutic.

Bradley G Thompson "Brad"Chairman/President/CEOKirk LookChief Financial Officer
Matthew C Coffey "Matt"COO/Co-FounderAlan J TuchmanSenior VP:Clinical/Chief Medical Ofcr
More Company Profile & Key Executives for ONY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil